Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$510K | 3 yrs ago

About eNeura Therapeutics

eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.

eNeura Therapeutics Headquarters Location

101 West Dickman Street Suite 900

Baltimore, Maryland, 21230,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing eNeura Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

eNeura Therapeutics is included in 3 Expert Collections, including Medical Devices.


Medical Devices

12,041 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health IT

7,901 items

eNeura Therapeutics Patents

eNeura Therapeutics has filed 8 patents.

The 3 most popular patent topics include:

  • Neurological disorders
  • Psychiatric diagnosis
  • Rare diseases
patents chart

Application Date

Grant Date


Related Topics




Cardiac arrhythmia, Neurotechnology, Neurological disorders, Neurophysiology, Neuropsychology


Application Date


Grant Date



Related Topics

Cardiac arrhythmia, Neurotechnology, Neurological disorders, Neurophysiology, Neuropsychology



Latest eNeura Therapeutics News

Transcranial Magnetic Stimulator Market Size, share 2021 Global Industry Trends, Growth Drivers, Demands, Business Opportunities and Demand Forecast to 2028 | eNeura, MagVenture A/S, Neurosoft, Brainsway, MAG & More GmbH, Neuronetics, Nexstim

Jun 21, 2021

| eNeura, MagVenture A/S, Neurosoft, Brainsway, MAG & More GmbH, Neuronetics, Nexstim Transcranial Magnetic Stimulator Market 2021 Analysis Report improves professional reputation and adds integrity to the work done such as refining business plan, preparing a presentation for a key client, or making recommendations to an executive. This report studies the global Transcranial Magnetic Stimulator market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. Transcranial Magnetic Stimulator market report provides basic information about Transcranial Magnetic Stimulator industry, definition, classification, application, industry chain structure, industry overview and international market analysis. In addition, company’s market share, possible sales volume, types of consumers, their response and views about the products, their thoughts for the step up of a product and the most appropriate method for the distribution of certain product have also been covered in Transcranial Magnetic Stimulator market study. Territorially, this report orders the creation, clear utilization, fare and import of Transcranial Magnetic Stimulator in North America, Europe, China, Japan, Southeast Asia and India. Transcranial Magnetic Stimulator Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1904.61 million by 2027 growing at a CAGR of 8.90% in the above-mentioned forecast period. Rising cases of neurological disorders is expected to create new opportunity for the market. Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry@ Brief Overview on Transcranial Magnetic Stimulator:                             Transcranial magnetic stimulator market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1904.61 million by 2027 growing at a CAGR of 8.90% in the above-mentioned forecast period. Rising cases of neurological disorders is expected to create new opportunity for the market. Transcranial magnetic stimulator is a non-invasive method which is used to induce nerve cells in the brain using magnetic fields to improve depression symptoms. Typically, TMS is used when other treatments for depression have not been successful. Increasing awareness about transcranial magnetic stimulator among professionals is expected to drive market. Some of the factors such as increasing cases of schizophrenia, technological advancement in transcranial magnetic stimulator devices, rising ageing population, less risk complication associated with the repetitive pulse transcranial magnetic stimulators, and rising prevalence of epilepsy is expected to drive the market growth. The Segments and Sub-Section of Transcranial Magnetic Stimulator Market are shown below: By Type (Deep Transcranial Magnetic Stimulator, Repetitive Transcranial Magnetic Stimulator, Others) By Application (Alzheimer’s Disease, Depression, Parkinson’s Disease, Epilepsy, Others) By Age Group (Adults, Children), End-Users (Research, Diagnostics, Therapeutics) List of TOP KEY PLAYERS in Transcranial Magnetic Stimulator Market Report are – eNeura Inc. ….. Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart) @ The report also focuses on global major leading industry players of Global Transcranial Magnetic Stimulator Market Share providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. Competitive analysis performed in this report puts forth the moves of the key players in the Transcranial Magnetic Stimulator industry such as new product launches, expansions, agreements, joint ventures, partnerships, and recent acquisitions. All the data, statistics, and information gathered to generate this report has been studied and analyzed with the established tools and techniques such as SWOT analysis and Porter’s Five Forces analysis. Global Transcranial Magnetic Stimulators Market Scope and Market Size Transcranial magnetic stimulators market is segmented on the basis of type, application, age group and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. On the basis of type, the market is segmented into deep transcranial magnetic stimulator, repetitive transcranial magnetic stimulator and others Based on application, the transcranial magnetic stimulators market is segmented into Alzheimer’s disease, depression, Parkinson’s disease, epilepsy and others Basis of age group, the transcranial magnetic stimulators market is segmented into adults and children On the basis of end- users, the market is segmented into research, diagnostics and therapeutics Scope of Report:                               The report Primarily studies the size, recent trends, and development status of the Transcranial Magnetic Stimulator market, as well as investment opportunities, market dynamics (such as driving factors, restraining factors), and industry news (like mergers, acquisitions, and investments). Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. This study categorizes the global Transcranial Magnetic Stimulator breakdown data by manufacturers, region, type and application, also analyses the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc. Data Sources & Methodology          The primary sources involve the industry experts from the Global Transcranial Magnetic Stimulator Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects. In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company’s Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weightage. For More Information or Query or Customization Before Buying, Visit@ KEY QUESTIONS ANSWERED: Study Explore COVID 19 Outbreak Impact Analysis What should be entry strategies, countermeasures to economic impact, and marketing channels? What are market dynamics? What is economic impact on market? What is market chain analysis by upstream raw materials and downstream industry? What is industry considering capacity, production and production value? What will be the estimation of cost and profit? What will be market share, supply and consumption? What about import and export? What is current market status? What’s market competition in this industry, both company, and country wise? What’s market analysis by taking applications and types in consideration? What were capacity, production value, cost and profit? Who are the global key players in this industry? What are their company profile, their product information, and contact information? Which manufacturing technology is used, what are their company profile, their product information, and contact information? Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. With tables and figures helping analyses worldwide Global Transcranial Magnetic Stimulator Market Forecast this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Strategic Points Covered in Table of Content of Global Transcranial Magnetic Stimulator Market: Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Global Transcranial Magnetic Stimulator market Chapter 2: Exclusive Summary – the basic information of the Global Transcranial Magnetic Stimulator Market. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Global Transcranial Magnetic Stimulator Chapter 4: Presenting the Global Transcranial Magnetic Stimulator Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis. Chapter 5: Displaying the by Type, End User and Region 2010-2020 Chapter 6: Evaluating the leading manufacturers of the Global Transcranial Magnetic Stimulator market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions. Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Global Transcranial Magnetic Stimulator Market is a valuable source of guidance for individuals and companies. To Know More Details, Visit in Depth Study Report @ Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. About Data Bridge Market Research, Private Ltd Data Bridge Market Research  Pvt  Ltd  is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market. Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve. Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include

eNeura Therapeutics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

eNeura Therapeutics Rank

  • When was eNeura Therapeutics founded?

    eNeura Therapeutics was founded in 2002.

  • Where is eNeura Therapeutics's headquarters?

    eNeura Therapeutics's headquarters is located at 101 West Dickman Street, Baltimore.

  • What is eNeura Therapeutics's latest funding round?

    eNeura Therapeutics's latest funding round is Unattributed VC.

  • How much did eNeura Therapeutics raise?

    eNeura Therapeutics raised a total of $58.1M.

  • Who are the investors of eNeura Therapeutics?

    Investors of eNeura Therapeutics include HealthCare Capital Partners, Abell Foundation, Camden Partners, Marc Blum, Fischell family and 9 more.

  • Who are eNeura Therapeutics's competitors?

    Competitors of eNeura Therapeutics include Verily Life Sciences, Theranica, Orchestra BioMed, Stimdia Medical, Cala Health, Lungpacer Medical, Saluda Medical, Cardionomic, Rune Labs, BrainQ and 48 more.

You May Also Like

Neuros Medical Logo
Neuros Medical

Neuros Medical focuses on the development of proprietary therapies for unmet needs to patients worldwide. The company’s patented platform technology, Electrical Nerve Block, focuses on the treatment of chronic pain in a variety of applications including post-amputation pain, chronic post surgical pain, and chronic migraine.

Synapse Biomedical Logo
Synapse Biomedical

Synapse Biomedical (SBI) was founded to commercialize the NeuRx Diaphragm Pacing System (DPS) that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.

Relievant Medsystems Logo
Relievant Medsystems

Relievant provides the underserved population with a low-risk therapy that can eliminate back pain while preserving other therapeutic options. The Company's Intracept System is a minimally invasive procedure that uses radiofrequency energy delivered through a small access tube into the vertebral body to ablate the Basivertebral nerve. The nerve, thought to significantly contribute to chronic low back pain, can no longer generate pain signals following ablation. The company was founded in 2004 and is based in Minneapolis, Minnesota.

Cala Health

Cala Health develops wearable neuromodulation therapies to deliver individualized peripheral nerve stimulation. It was founded in 2014 and is based in San Mateo, California.

Aleva Neurotherapeutics Logo
Aleva Neurotherapeutics

Aleva Neurotherapeutics develops next-generation implants for Deep Brain Stimulation (DBS) therapy that are designed to be versatile, more precise, and more efficient than currently available DBS approaches, while causing fewer side effects and complications. Aleva's microDBS technology is based on thin film microscale electrodes, which are non-toxic and bio-compatible. It allows for precise, target-specific brain stimulation which reduces the side effects and potential complications as well as the costs of DBS therapy. Moreover, its features allow for expanding the existing DBS market to new indications which cannot be addressed by currently available technologies.

Noctrix Health

Noctrix Health is developing therapeutic wearables that empower patients to take control of their chronic medical conditions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.